Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03215511
Title A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bayer
Indications

Advanced Solid Tumor

congenital mesoblastic nephroma

congenital fibrosarcoma

Therapies

Selitrectinib

Age Groups: child | senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | BEL


No variant requirements are available.